The Biology of Non-Response: What Is Actually Happening Non-response to GLP-1 RAs is not a monolithic phenomenon
I'm feeling healthier and more confident every week
If 10% of Indias obese population (10 million people) were on GLP-1 therapy at an average cost of 5,000/month, thats a 6,000 crore annual market from generics alone
Limitation of Liability: To the fullest extent permitted by applicable law, MEDVi, LLC, its officers, directors, employees, affiliates, partners, contractors, and agents disclaim all liability for any direct, indirect, incidental, consequential, special, exemplary, or punitive damages arising from use of the platform's services, reliance on information in this release, treatment outcomes, medication side effects, or any other matter related to services described
How Mounjaro Works Mounjaro contains tirzepatide, a once-weekly injectable peptide that acts as a dual agonist at two gut hormone receptors: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)
One primary difference between Mounjaro and Ozempic is that Ozempic is FDA-approved to reduce the risk of heart attack and stroke in people with type 2 diabetes, while Mounjaro is not